🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
This partially randomized phase Ib/II trial studies the side effects and be...
Status
Terminated
Location
University of Alabama, Birmingham
Start Date
2015-06
Trial ID
NCT02457910
Treatments Being Tested
The purpose of this study is to determine whether the combination of As2O3 ...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02757040
Treatments Being Tested
This phase I trial studies the side effects and best dose of PI3K inhibitor...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-05
Trial ID
NCT01540253
This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-09-03
Trial ID
NCT01816594
Treatments Being Tested
The purpose of this study is to test the safety of combined use of the stud...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2018-08-23
Trial ID
NCT03581942
Treatments Being Tested
Clinical study of HEC68498 in patients with advanced refractory solid tumor...
Status
Completed
Location
The Fifth Medical Center of PLA Ceneral Hospital
Start Date
2019-02-27
Trial ID
NCT04324372
Treatments Being Tested
To characterize safety, tolerability and to establish the maximum tolerated...
Status
Terminated
Location
University of Chicago
Start Date
2018-07-18
Trial ID
NCT03471351
Treatments Being Tested
This is a prospective single-arm, multicenter, phase Ib clinical trial of P...
Status
Terminated
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2022-02-20
Trial ID
NCT05083208
Treatments Being Tested
This is a Phase II, single-arm study to evaluate the efficacy, safety, and ...
Status
Unknown
Location
MD Anderson Cancer Center
Start Date
2022-05-01
Trial ID
NCT05274997
Treatments Being Tested